A Randomized, Multicenter, Double-blind, Placebo-controlled, Dose-range-finding, Parallel-group, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation

Trial Profile

A Randomized, Multicenter, Double-blind, Placebo-controlled, Dose-range-finding, Parallel-group, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Mar 2013

At a glance

  • Drugs Linaclotide (Primary)
  • Indications Constipation
  • Focus Therapeutic Use
  • Sponsors Ironwood Pharmaceuticals
  • Most Recent Events

    • 31 Dec 2009 Results published in Gastroenterology.
    • 20 May 2008 Results have been presented at the Digestive Disease Week conference, reported by Ironwood Pharmaceuticals and Forest Laboratories in a media release.
    • 14 May 2008 Status changed from in progress to completed, reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top